基本药物制度下药品费用可负担性实证分析  

An evidence-base study on the affordablity of essential drugs in Essential Medicine System

作　　者：李显文[1] 章燕丽[1] 吴森林[1] 梁慧军 

机构地区：[1]浙江医学高等专科学校,浙江杭州310053 [2]浙江省嘉兴市秀洲区新塍镇社区卫生服务中心,浙江嘉兴314015

出　　处：《中国农村卫生事业管理》2013年第1期10-13,共4页Chinese Rural Health Service Administration

基　　金：浙江省医药卫生科技计划(2011KYB007)

摘　　要：参照世界卫生组织推荐的方法,选取30种核心药物,调查同类同质药品的品牌药和仿制药价格,并选择8种常见疾病,按照标准治疗指南,计算所需药品费用及相当于最低日薪天数。结果发现,不同品种、不同类别药品费用可负担性有差异,品牌药较差,仿制药较好;不同类机构间药品费用可负担性有差异,公立机构较差,药店较好;不同类机构均有常见病治疗药品缺乏等。提出积极扶持和促进常见疾病仿制药的生产供应;提高医疗保障水平,关注低收入人群的药品费用可负担性;改进药品定价和招采制度,缩小公立机构品牌药与仿制药的价格差距;实行动态监测防止廉价药品紧缺等措施。The study design was based on the methodology which was developed by the World Health Organization and Health Action International （WHO/HAD. The data were collected from a total of 9 public sector facilities and 8 retail pharmacies in four districts in Zhejiang province. The treatment cost was based on the medicine prescribed at a standard dose of the WHO/HAI manual and was calculated using the price data collected in these facilities. The afford- ability of treatment was analyzed on the treatment cost and the daily wage of the lowest paid unskilled workers. It is found that there are differences in affordability among different kinds of drugs,and also between the public facilities and retail pharmacies,between the brands and the equivalents. Affordability of treatment with the generic equivalents is better than that with the brands, in retail pharmacies better than in public facilities. It is proposed that the production and provision of the generic equivalents should be intensified, the level of medical security should be improved and the low--income people should be more cared. The drug pricing system and procurement system should be improved in or- der to narrow the price gap of brand drugs and generic equivalents in public institutions and dynamic monitoring should be implemented to prevent the shortage of inexpensive medicines.

关 键 词：药品费用 可负担性 基本药物制度 

分 类 号：R95[医药卫生—药学]